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Although fixation of the stapes is usually progressive and secondary to otosclerosis, it may present congenitally,
with other skeletal manifestations, as an autosomal dominant syndrome—such as proximal symphalangism
(SYM1) or multiple-synostoses syndrome (SYNS1), both of which are caused by mutations in NOG, the gene
encoding noggin. We describe a family that was ascertained to have nonsyndromic otosclerosis but was subse-
quently found to have a congenital stapes ankylosis syndrome that included hyperopia, a hemicylindrical nose,
broad thumbs and great toes, and other minor skeletal anomalies but lacked symphalangism. A heterozygous
nonsense NOG mutation—c.328CrT (Q110X), predicted to truncate the latter half of the protein—was iden-
tified, and a heterozygous insertion in NOG—c.252-253insC, in which the frameshift is predicted to result in
96 novel amino acids before premature truncation—was identified in a previously described second family with
a similar phenotype. In contrast to most NOG mutations that have been reported in kindreds with SYM1 and
SYNS1, the mutations observed in these families with stapes ankylosis without symphalangism are predicted to
disrupt the cysteine-rich C-terminal domain. These clinical and molecular findings suggest that (1) a broader
range of conductive hearing-loss phenotypes are associated with NOG mutations than had previously been
recognized, (2) patients with sporadic or familial nonsyndromic otosclerosis should be evaluated for mild features
of this syndrome, and (3) NOG alterations should be considered in conductive hearing loss with subtle clinical
and skeletal features, even in the absence of symphalangism.
Stapes ankylosis is characterized by conductive hearing
loss due to congenital or acquired fixation of the stapes.
Conductive hearing loss results from impairment of the
sound-conduction mechanism (the external auditory ca-
nal, tympanic membrane, and/or middle-ear ossicles). In
contrast, sensorineural hearing loss may be caused by
disorders of the cochlea, acoustic nerve, or brainstem.
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Otosclerosis (MIM 166800), the most common cause of
progressive conductive hearing loss in adults, is generally
manifested as nonsyndromic, delayed-onset, conductive
hearing loss, but it may also affect the inner ear to cause
sensorineural loss. Congenital stapes ankylosis may be
difficult to differentiate from otosclerosis when the di-
agnosis of conductive hearing loss is delayed. Stapes an-
kylosis may be associated with skeletal dysplasias, such
as osteogenesis imperfecta type I (MIM 166200), or may
be present as an isolated temporal bone anomaly, such
as X-linked stapes fixation with perilymphatic gusher
(DFN3 [MIM 304400]). Furthermore, skeletal anoma-
lies associated with stapes ankylosis may be subtle, such
that a syndrome is not recognized.
Mutations inNOG (MIM 602991), the gene encoding
noggin, have been identified in two such stapes ankylosis
syndromes—namely, proximal symphalangism (SYM1
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Figure 1 Pedigree of family 16. (A key to phenotypes is given in the circle. CHL p conductive hearing loss; ROM p range of motion.)
The arrow (↗) denotes the proband. Square symbols denote male patients, and circles denote female patients; blackened symbols denote affected
individuals, and unblackened symbols denote unaffected individuals; each quadrant defines a phenotypic element or a set of phenotypic elements,
and blackened quadrants indicate the presence of the corresponding phenotypic element(s). Asterisks (*) indicate family members who underwent
complete genetic, otolaryngological, ophthalmologic, and radiological evaluations. Horizontal bars (—) indicate family members who were
personally examined by an investigator (D.J.B.).
[MIM 185800]) and multiple-synostoses syndrome
(SYNS1 [MIM 186500]) (Gong et al. 1999; Takahashi
et al. 2001; Mangino et al. 2002). NOG encodes a se-
creted protein, noggin, that is essential for normal bone
and joint development in both humans and mice (Zim-
merman et al. 1996). Noggin binds and inactivates bone
morphogenetic proteins (BMPs), which are specific sig-
naling proteins belonging to the transforming growth
factor–b superfamily. SYM1, also known as “Cushing
symphalangism,” consists of stapes ankylosis, proximal
interphalangeal joint fusion, and skeletal anomalies.
SYNS1, also known as “facio-audio-symphalangism,”
is similar to SYM1 but has the additional feature of a
broad hemicylindrical nose.
In this study, we ascertained a family of Italian descent
(family 16) that had conductive hearing loss that was
inherited as an autosomal dominant trait with complete
penetrance (fig. 1). Each affected individual was thought
to have had nonsyndromic otosclerosis before participa-
tion in this study. The University ofMichigan institutional
review board approved the study, and each family mem-
ber gave informed consent and completed a questionnaire.
Venous-blood samples were obtained from 11 family
members (8 affected members, 1 unaffectedmember, and
2 spouses). DNA was extracted from the blood samples
by use of standard methodology (PureGene DNA Iso-
lation Kit; Gentra).
The NOG coding region was first amplified from ge-
nomic DNA by PCR with forward (5′-GGACGCGGGA-
CGAAGCAGCAG-3′) and reverse (5′-GAGGATCAAG-
TGTCCGGGTGC-3′) primers that were designed from
the human NOG cDNA sequence, by use of conditions
described elsewhere (Gong et al. 1999), and was then
bidirectionally sequenced with an ABI 3700 automated
DNA sequencer (Applied Biosystems) at the University
of Michigan DNA Sequencing Core. Each PCR product
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Table 1
Physical Examination Findings for the Four Members of Family 16
Who Were Examined at the University of Michigan
Feature
No.
Affected
Posteriorly sloping forehead 4
Prominent supraorbital ridges 3a
Broad, hemicylindrical nose with bulbous tip
and short philtrum 4
Nasal tip cleft 3a
Mild malar flattening 4
Chin cleft 2
Mild synophrys 3a
Limited neck range of motion 3a
Limited elbow flexion, extension, and supination 3a
Limited wrist dorsiflexion 3a
Broad thumbs with foreshortened nails 4
Limited hip range of motion 3a
Soft-tissue syndactyly of toes 2 and 3 4
Broad and short great toes 4
Pes planus 2
NOTE.—II:1, III:1, III:4, and IV:1 were examined at the University
of Michigan.
a Absent in IV:1 (at age 12 years).
Table 2
Plain-Film Radiology Findings for the Four Members of Family 16
Who Were Examined at the University of Michigan
Feature
No.
Affected
Degenerative spine changes 4
Abnormal humero-radial joint morphology 4
Broad and short thumbs and toes 4
Slightly broad metacarpals 2
Premature fusion of thumb distal phalangeal growth
plates 1a
Slight inferior narrowing of pelvis 3
Premature fusion of the growth plates of great-toe
proximal phalanges 1a
Partial fusion of right-5th-toe distal
interphalangeal joint 1b
NOTE.—II:1, III:1, III:4, and IV:1 were examined at the University
of Michigan.
a Found only in IV:1 (at age 12 years).
b Normal variant.
was eluted on a 1% low-melting-point agarose (Ultra-
PURE; GibcoBRL) gel and then was purified using stan-
dard methodology (QIAquick Gel Extraction Kit). In
addition, the NOG coding region was sequenced in 100
control DNA samples, of which 90 were from the DNA
Polymorphism Discovery Resource (Collins et al. 1998)
and 10 were from the Italian Human Variation Panel
(Coriell Cell Repositories).
Conductive hearing loss was documented at age 4
years in two family members and remained stable through
subsequent years—consistent with congenital stapes an-
kylosis, rather than otosclerosis. All affected family mem-
bers except III:4 have hyperopia, or farsightedness, and
the age at which corrective lenses were required varied
from 2 to 22 years. The median spherical equivalent for
all affected eyes was 4.75 diopters (D), with a mean of
5.50 D (range 1.25 D to 10.00 D). Keratometry
readings, which provide a measure of corneal curvature,
were in the normal range for II:1 and III:4 and were
slightly steeper for III:1 and IV:1. Biomicroscopy showed
a cataract change in II:1 that was age appropriate. Both
II:1 and III:1 had Brushfield spots, a normal iris variant
without known clinical significance. The three affected
family members who were examined were all found to
have shorter-than-average axial lengths: 21.19mm oculus
dexter (OD) (right eye) and 22.52mm oculus sinister (OS)
(left eye) for II:1, 20.40 mm OD and 20.42 mm OS for
III:1, and 22.02 mm OD and 22.52 mm OS for III:4.
The phenotype in family 16 is characterized by auto-
somal dominant stapes ankylosis with broad thumbs and
toes and hyperopia, as well as other minor skeletal anom-
alies (fig. 1 and table 1). Radiological findings are sum-
marized in table 2. Symmetrically short distal thumb
phalanges were noted in each family member. No ev-
idence of symphalangism was evident in hand radio-
graphs of any of the four family members who were
examined. Review of hand photographs of III:3 revealed
broad and dysmorphic middle fingers and great toes but
normal thumb morphology.
We then analyzed NOG in family 16 and in three
members of a family that was described by Milunsky
et al. (1999) (family G) and that had a similar phe-
notype. In family 16, a heterozygous nonsense muta-
tion—1139CrT, or c.328CrT (Q110X)—was found
in all eight affected family members (fig. 2A), but not
present in the reference sequence (GenBank accession
numbers U31202 and NM_005450). In the two af-
fected members of family G, a 1-bp insertion, 1063-
1064insC (c.252-253insC), caused a frameshift that,
before encountering a premature stop codon, leads to
a mutant peptide with 96 novel amino acids (figs. 2B
and 2C). Neither mutation was found in unaffected
family members, spouses, or 100 control samples. In
addition, NOG sequencing data from the 100 control
samples revealed no variations, as compared to the ref-
erence sequence. A comparison of the wild-type and
mutant proteins is presented in figure 3. To confirm
the 252-253insC mutation, we cloned the PCR prod-
ucts into pGEM-T Easy vectors (Promega), used liga-
tion products to transform DH5a-competent Esche-
richia coli cells, and isolated the plasmid DNA (Wizard
Plus SV Minipreps; Promega). Through sequencing, we
confirmed the presence of both the mutant and wild-
type alleles in the population of subclones.
Two other families that had stapes ankylosis with
broad thumbs and toes (MIM 184460) and hyperopia
have been clinically described elsewhere (Teunissen and
Figure 2 Sequence chromatograms. A, Chromatogram from sequencing of forward strand, demonstrating NOG mutations in affected
members of family 16 (top) versus control samples (bottom). The asterisk (*) denotes overlapping peaks—indicating heterozygous mutation
c.328CrT (Q110X), not present in control samples. B, Chromatogram from sequencing of forward strand in affected member of family G
(top)—demonstrating heterozygous mutation c.252-253insC—as compared to control samples (bottom). Text between chromatograms indicate
the sequence of the mutant strand (line 1) and the sequence of the wild-type strand (line 2), aligned with corresponding heterozygous peaks
on the top chromatogram. C, Chromatogram from sequencing of reverse strand in the affected member of family G (top) and control samples
(bottom). A heterozygous 1-bp insertion leads to a frameshift (shaded sequence), as compared to the wild-type sequence.
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Figure 3 Comparison of noggin sequences among wild-type human noggin (line 1), among c.328CrT and c.252-253insCmutations (lines
2 and 3, respectively) that cause stapes ankylosis with broad thumbs and toes and hyperopia, and among previously reported mutations that
cause SYM1 (c.386TrA [line 4]) and SYNS1 (c.58delC [line 5]). Shading indicates novel amino acids caused by frameshift mutations. Asterisks
(*) indicate stop codons. Bullets (•) indicate conserved cysteine residues.
Cremers 1990; Hilhorst-Hofstee et al. 1997) without
detailed description of the ophthalmological findings.
The syndromes diagnosed in families G and 16 share
several features with these syndromes, as well as with
SYM1 and SYNS1 (table 3). The key features that dif-
ferentiate stapes ankylosis with broad thumbs and toes
and hyperopia from SYM1 and SYNS1 include a char-
acteristic physiognomy, hyperopia, and the absence of
cervical vertebral fusion and symphalangism. In contrast
to SYM1 and SYNS1, the affected members of family
16 have dysmorphic digits and limitation of joint move-
ment that is not attributable to bony joint fixation.
NOG was first discovered in an expression screen for
signaling molecules that are produced by the Spemann
organizer, which is important in the development of the
dorsal-ventral axis (Smith and Harland 1992). In early
development, the noggin/BMP pathways play an im-
portant role in both determination of retinal-cell fate in
chick (Moore andMoody 1999; Belecky-Adams andAd-
ler 2001) and ocular growth and lens induction in chick
(Trousse et al. 2001) and mouse (Furuta and Hogan
1998). Direct implications for the noggin/BMPpathways
in human ocular development have yet to be elucidated.
Numerous skeletal features found in all affected adults
in family 16 were absent in the affected child, suggesting
that NOG mutations also have effects in postnatal
growth and development. Premature fusion of growth
plates may contribute to the joint dysfunction that was
observed. Characteristic facial features may also be as-
sociated withNOGmutations, since noggin, BMPs, and
retinoic acid together play a role in development of the
frontonasal and the maxillary facial structure in some
species (Lee et al. 2001). Family G is ofMexican descent,
and the differences in stature between family 16 (90th
percentile) and family G (25th–50th percentile) may re-
sult from allelic differences in modifier genes, rather than
from specific effects of different NOG mutations. Tall
stature has not been reported with other NOG muta-
tions and, overall, is uncommon in skeletal dysplasias.
NOG consists of a single exon without introns and
encodes the protein noggin, which is 232 amino acids
long. NOG is highly conserved, with 97% identity be-
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Table 3
Comparison between Phenotypes Observed in Family 16 and Those in Families Described Elsewhere
FAMILY 16 [NO.
AFFECTED/TOTAL]
FAMILY DESCRIBED BY
SYM1a SYNS1a
Milunsky et al.
(1999) (Family G)
Teunissen and
Cremers (1990)
Hilhorst-Hofstee
et al. (1997)
Autosomal dominant      
Stapes ankylosis  [8/8]     
Hyperopia  [7/8]    b 
Fused cervical vertebrae  [0/8]    b 
Hemicylindrical nose  [8/8]    b 
Broad thumbs and toes  [8/8]c    d 
Symphalangism  [0/8]  b b  
Syndactyly  [8/8]     
Carpal/tarsal fusions  [0/4]     
Tall stature (90th percentile)  [8/8]     
NOG mutation   U U  
NOTE.— p Present;  p absent; U p unknown.
a Based on aggregate data from Hilhorst-Hofstee et al. (1997).
b Individual case reported.
c One individual had normal thumbs but broad toes and middle fingers.
d Rarely reported.
tween the human and mouse cDNA sequences, and the
human andmouse proteins are identical. Consistentwith
this finding, we observed no variations, among 100 con-
trol samples, in the NOG sequence. Noggin is post-
translationally modified and is secreted as a homodimer
that is linked by disulfide bonds (Smith et al. 1993). After
secretion of the protein, the N-terminus (amino acids
1–19) is proteolytically cleaved from the mature noggin
peptide, and the remaining peptide is glycosylated. The
sequence of the signal peptide region is somewhat var-
iable across species (Valenzuela et al. 1995). The C-ter-
minal portion (amino acids 155–232) of noggin contains
a series of nine conserved cysteine residues that are
thought to be important in disulfide-bond formation (fig.
3). Alternatively, these cysteine residues may form a cys-
teine-knot motif, as described in other BMP antagonists
(Vitt et al. 2001).
Noggin knockout mice have grossly dysmorphic skel-
etal development and die prenatally, whereas heterozy-
gous noggin null mutants have a phenotype that is in-
distinguishable from wild type (Brunet et al. 1998). In
contrast, both genetic and biochemical studies demon-
strate that heterozygous missense or nonsenseNOGmu-
tations can cause human disease. Mutant noggin proteins
that contain single-amino-acid substitutions underlying
SYM1 and SYNS1 had normal function in Xenopus, in
terms of BMP binding and dorsalizing activity (Marcelino
et al. 2001). In COS-7 cells, the mutants were secreted
and dimerized with varying efficiency, sometimes in a
monomeric and/or non–disulfide-bonded form, but pres-
ence of the mutant protein did not appear to affect di-
sulfide dimerization of the wild-type protein. Marcelino
et al. (2001) suggest that noggin has species-specific and
joint-specific effects, dependent on the amount of func-
tional protein.
The c.328CrT and c.252-253insC mutations both
result in a polypeptide that lacks the cysteine-rich C-
terminal domain. In contrast, most NOG mutations
that are associated with SYM1 and SYNS1 are hetero-
zygous missense mutations (Gong et al. 1999; Taka-
hashi et al. 2001; Mangino et al. 2002). Two nonsense
mutations—c.386TrA (L129X) and c.58delC, which
have been reported in a family with SYM1 and a family
with SYNS1, respectively (Takahashi et al. 2001)—also
result in the deletion of the C-terminal domain (fig. 3).
Differences in genetic background control the expres-
sion of exencephaly in noggin knockout mice (McMa-
hon et al. 1998) and may also explain why similar ge-
netic mutations in humans result in variable phenotypes.
Alternatively, there may be other, as-yet-unknown nog-
gin subdomains, such as BMP-binding sites, that explain
the different phenotypic effects of these mutations.
The phenotype of stapes ankylosis with broad thumbs
and toes and hyperopia that is associated with these mu-
tations is consistent with the role that noggin plays in the
development and maintenance of normal joint function,
in conjunction with normal skeletal growth. Further stud-
ies will be necessary to determine if the mutant polypep-
tides that result from these mutations are properly tran-
scribed, translated,modified, dimerized, and secreted.The
association between stapes ankylosis and other physical
features that are subtle or otherwise common in the gen-
eral population may sometimes remain unrecognized.
Families with apparent autosomal dominant otosclerosis
or other types of conductive hearing loss should have a
complete physical and radiological examination, to ex-
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clude subtle skeletal features found in the spectrum of
stapes ankylosis syndromes that are caused byNOGmu-
tations. Finally,NOG and/or other genes that are involved
in the noggin/BMP pathway should be considered as can-
didate genes for these disorders.
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